title: Individualized Pazopanib Dosing-Letter.
authors.affiliation: Department of Cancer Medicine, Gustave Roussy Cancer Campus, Villejuif, France. olivier.mir@gustaveroussy.fr.
authors.forename: Olivier
authors.initials: O
authors.lastname: Mir
authors.affiliation: Department of Pharmacology, Gustave Roussy Cancer Campus, Villejuif, France.
authors.forename: Sophie
authors.initials: S
authors.lastname: Broutin
authors.affiliation: Department of Cancer Medicine, Gustave Roussy Cancer Campus, Villejuif, France.
authors.forename: Audrey
authors.initials: A
authors.lastname: Perret
authors.affiliation: Department of Cancer Medicine, Gustave Roussy Cancer Campus, Villejuif, France.
authors.forename: Axel
authors.initials: A
authors.lastname: Le Cesne
authors.affiliation: Department of Pharmacology, Gustave Roussy Cancer Campus, Villejuif, France.
authors.forename: Angelo
authors.initials: A
authors.lastname: Paci
mesh_terms: D006801:Humans; D007191:Indazoles; D011743:Pyrimidines; D013449:Sulfonamides
chemical_list: D007191:Indazoles; D011743:Pyrimidines; D013449:Sulfonamides; C516667:pazopanib